Comorbidities and neighborhood factors associated with prescription of sodium-glucose cotransporter protein-2 inhibitors and glucagon-like peptide-1 receptor agonists among medically underserved populations.

Ogunsanmi DO, Harrison AT, Pakker AR, Kovesdy CP, Bailey JE, Surbhi S

Open source

DOI
10.18553/jmcp.2023.29.6.699
Published
2023 Jun
Container
Journal of managed care & specialty pharmacy
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.18553/jmcp.2023.29.6.699,
  title = {Comorbidities and neighborhood factors associated with prescription of sodium-glucose cotransporter protein-2 inhibitors and glucagon-like peptide-1 receptor agonists among medically underserved populations.},
  author = {Ogunsanmi DO and Harrison AT and Pakker AR and Kovesdy CP and Bailey JE and Surbhi S},
  year = {2023},
  journal = {Journal of managed care \& specialty pharmacy},
  doi = {10.18553/jmcp.2023.29.6.699},
  url = {https://doi.org/10.18553/jmcp.2023.29.6.699}
}

RIS

TY  - JOUR
TI  - Comorbidities and neighborhood factors associated with prescription of sodium-glucose cotransporter protein-2 inhibitors and glucagon-like peptide-1 receptor agonists among medically underserved populations.
AU  - Ogunsanmi DO
AU  - Harrison AT
AU  - Pakker AR
AU  - Kovesdy CP
AU  - Bailey JE
AU  - Surbhi S
PY  - 2023
JO  - Journal of managed care & specialty pharmacy
DO  - 10.18553/jmcp.2023.29.6.699
UR  - https://doi.org/10.18553/jmcp.2023.29.6.699
ER  - 

APA

DO, O., AT, H., AR, P., CP, K., JE, B., & S, S. (2023). Comorbidities and neighborhood factors associated with prescription of sodium-glucose cotransporter protein-2 inhibitors and glucagon-like peptide-1 receptor agonists among medically underserved populations.. Journal of managed care & specialty pharmacy. https://doi.org/10.18553/jmcp.2023.29.6.699

Source records